Open Collections

UBC Faculty Research and Publications

Treatment of Gastroesophageal Reflux Disease (GERD) Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 3 discusses treatment of gastroesophageal reflux disease (GERD). GERD symptoms should be treated with antacids or H2-blockers as much as possible. In refractory cases omeprazole is effective. Long term omeprazole is indicated in relapsing severe erosive esophagitis, but must be prescribed with caution until more is known about long term safety.

Item Metadata

Title
Treatment of Gastroesophageal Reflux Disease (GERD)
Alternate Title
Therapeutics Letter 3
Creator
Therapeutics Initiative (University of British Columbia)
Date Issued
1994-12
Description
Therapeutics Letter 3 discusses treatment of gastroesophageal reflux disease (GERD). GERD symptoms should be treated with antacids or H2-blockers as much as possible. In refractory cases omeprazole is effective. Long term omeprazole is indicated in relapsing severe erosive esophagitis, but must be prescribed with caution until more is known about long term safety.
Subject
Antacids; Esophagitis; Gastroesophageal Reflux; Histamine H2 Antagonists; Omeprazole; Peptic Ulcer 
Genre
Other
Type
Text
Language
eng
Notes
The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.
Date Available
2023-06-20
Provider
Vancouver : University of British Columbia Library
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
DOI
10.14288/1.0433582
URI
http://hdl.handle.net/2429/84992
Affiliation
Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of
Peer Review Status
Reviewed
Scholarly Level
Faculty; Researcher
Rights URI
http://creativecommons.org/licenses/by-nc-nd/4.0/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International